The Inside Edge · member commentary, performance grid, watch list, weekly essay
Concentration is the trade. We have to be willing to live with it.
The Advising Alpha model portfolios are concentrated by design. Core 20 holds roughly 20 positions. BioTech 10 and Apex Momentum hold 10 each. A broad index holds 500.
Concentration is the structural mechanism that lets a portfolio beat the index over time. It is also the mechanism that produces larger drawdowns and longer divergences, the stretches that make the strategy uncomfortable to hold.
There is no way around the tradeoff. A portfolio that owns one of everything cannot beat the average. A portfolio built to beat the average has to look meaningfully different from it, and the cost of looking different is the occasional period when the difference runs against you.
We are explicit about this because it is the most common reason members second guess the strategy during a rough patch. These portfolios are not chasing the index plus a point with low active risk. They are built to win by meaningful margins over decades, which requires accepting meaningfully more variability along the way. Worth reading twice now. Worth reading again during any drawdown.
The performance grid, watch list, trade activity, and essay continue here.
Pro is $349 per year. The rate locks for life as long as your subscription stays current. 14 day money back guarantee.
Start Pro for $349/year →Already a member? Sign in to read the full issue.
The Inside Edge is a member publication of Advising Alpha. We are a publisher under Section 202(a)(11)(D) of the Investment Advisers Act of 1940, not a registered investment adviser. Past performance does not guarantee future results. Full disclaimer at advisingalpha.com/disclaimer.